"We have invested eight million euros (Rs 55 crores) for setting up a manufacturing plant in Chennai and will pump in another eight million euros in expanding its capacity in the next two years," B Braun Vascular System Senior Vice-President Gerd Wacker told PTI.
The company has formed a subsidiary 'B Braun Medical India Pvt Ltd' to look after its business in India.
It has got the approval of Drug Controller General of India (DCGI) for introducing around 12 medical devices across different therapeutic areas and is also waiting for DCGI nod to introduce another five products in the country.
Apart from hospital care, the company is operating in India in anasthetics and Surgical instruments.
B Braun has set up a manufacturing unit in Chennai for manufacturing cardiovascular equipments. From this centre the company exports devices to other countries, too. Besides this, the company is also initiating a phase IV clinical trial for its medical device 'drug eluting balloons' used in the treatment of heart arteries and has plans to launch it in the next year.It also announced the launch of its next generation device 'drug eluting stent' (DES) used for the treatment of defected coronaries.
"In 2008, we are expecting a revenue of Rs 160 crore and by 2010, when all our projects would start contributing to our revenues, it should cross Rs 250 crore," B.Braun Medical India Business Unit Manager Vascular System Indranil Mukherji said.
